A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to investigate the safety, tolerability, pharmacokinetics and
catechol-O-methyltransferase (COMT) activity of BIA 9-1067 in healthy male subjects after
single oral ascending doses.